Heart Transplantation

• 

  Subject Areas on Research

  • 2017 ACC/AHA/HFSA/ISHLT/ACP Advanced Training Statement on Advanced Heart Failure and Transplant Cardiology (Revision of the ACCF/AHA/ACP/HFSA/ISHLT 2010 Clinical Competence Statement on Management of Patients With Advanced Heart Failure and Cardiac Transplant): A Report of the ACC Competency Management Committee. 
  • 2017 ACC/AHA/HFSA/ISHLT/ACP Advanced Training Statement on Advanced Heart Failure and Transplant Cardiology (Revision of the ACCF/AHA/ACP/HFSA/ISHLT 2010 Clinical Competence Statement on Management of Patients With Advanced Heart Failure and Cardiac Transplant): A Report of the ACC Competency Management Committee. 
  • 2017 ACC/AHA/HFSA/ISHLT/ACP Advanced Training Statement on Advanced Heart Failure and Transplant Cardiology (Revision of the ACCF/AHA/ACP/HFSA/ISHLT 2010 Clinical Competence Statement on Management of Patients With Advanced Heart Failure and Cardiac Transplant): A Report of the ACC Competency Management Committee. 
  • 2020 ACC/HFSA/ISHLT Lifelong Learning Statement for Advanced Heart Failure and Transplant Cardiology Specialists: A Report of the ACC Competency Management Committee. 
  • A Comprehensive Risk Score to Predict Prolonged Hospital Length of Stay After Heart Transplantation. 
  • A Contemporary Analysis of Heart Transplantation and Bridge-to-Transplant Mechanical Circulatory Support Outcomes in Cardiac Sarcoidosis. 
  • A Porcine Heterotopic Heart Transplantation Protocol for Delivery of Therapeutics to a Cardiac Allograft. 
  • A bridge for the 21st century in heart transplantation? 
  • A change of heart. 
  • A change of heart: Preliminary results of the US 2018 adult heart allocation revision. 
  • A contemporary review of mechanical circulatory support. 
  • A history of orthotopic heart transplantation. 
  • A human CD46 transgenic pig model system for the study of discordant xenotransplantation. 
  • A model of sequential heart and composite tissue allotransplant in rats. 
  • A new rat infection-heart transplant model: effect of infection on graft survival studies. 
  • A normothermic ex vivo organ perfusion delivery method for cardiac transplantation gene therapy. 
  • A report of the first pediatric heart transplant following donation after circulatory death in the United States using ex-vivo perfusion. 
  • A role for fractalkine and its receptor (CX3CR1) in cardiac allograft rejection. 
  • A six-month-old boy with neonatal lupus and cardiac enlargement. 
  • A team-based approach to patients in cardiogenic shock. 
  • ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices) developed in collaboration with the American Association for Thoracic Surgery and Society of Thoracic Surgeons. 
  • ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices): developed in collaboration with the American Association for Thoracic Surgery and Society of Thoracic Surgeons. 
  • ACC/AHA/HRS 2008 Guidelines for device-based therapy of cardiac rhythm abnormalities. 
  • Abdominal complications in organ transplant recipients. 
  • Absence of hyperacute rejection in newborn pig-to-baboon cardiac xenografts. 
  • Acute and chronic phagocyte determinants of cardiac allograft vasculopathy. 
  • Acute hemodynamic changes after rapid intravenous bolus dosing of dexmedetomidine in pediatric heart transplant patients undergoing routine cardiac catheterization. 
  • Acute lower extremity ischemia after cardiac surgery. 
  • Acute vascular rejection and accommodation: divergent outcomes of the humoral response to organ transplantation. 
  • Adenovirus-mediated gene transfer into rat cardiac allografts. Comparison of direct injection and perfusion. 
  • Adenovirus-mediated gene transfer of the beta2-adrenergic receptor to donor hearts enhances cardiac function. 
  • Adenovirus-mediated genetic manipulation of the myocardial beta-adrenergic signaling system in transplanted hearts. 
  • Advanced Heart Failure: Epidemiology, Diagnosis, and Therapeutic Approaches. 
  • Advanced heart failure patients supported with ambulatory inotropic therapy: What defines success of therapy? 
  • Advanced therapies for end-stage heart failure. 
  • Advances in the surgical treatment of heart failure. 
  • Allograft dendritic cell p40 homodimers activate donor-reactive memory CD8+ T cells. 
  • Allosensitization in cardiac transplantation: shooting at a moving target. 
  • Altered distribution of H60 minor H antigen-specific CD8 T cells and attenuated chronic vasculopathy in minor histocompatibility antigen mismatched heart transplantation in Cxcr3-/- mouse recipients. 
  • American Association for Thoracic Surgery/International Society for Heart and Lung Transplantation guidelines on selected topics in mechanical circulatory support. 
  • American Association for Thoracic Surgery/International Society for Heart and Lung Transplantation guidelines on selected topics in mechanical circulatory support. 
  • Amiodarone use in patients listed for heart transplant is associated with increased 1-year post-transplant mortality. 
  • An infant with subvalvar and valvar aortic stenosis, subvalvar and valvar pulmonary stenosis, severe biventricular hypertrophy and pulmonary hemorrhage. 
  • An unusual case of ventricular fibrillation. 
  • Analysis of myocardial function in orthotopic cardiac allografts after prolonged storage in UW solution. 
  • Anesthetic management of the patient with extracorporeal membrane oxygenator support. 
  • Angiotensin II: an immune costimulator? 
  • Anti-CD20 monoclonal antibody (rituximab) therapy for acute cardiac humoral rejection: a case report. 
  • Antibody-mediated rejection of the lung: A consensus report of the International Society for Heart and Lung Transplantation. 
  • Antisense oligodeoxynucleotides prevent acute cardiac allograft rejection via a novel, nontoxic, highly efficient transfection method. 
  • Aortic counterpulsation: a review of the hemodynamic effects and indications for use. 
  • Aortic valve replacement in a diseased bicuspid valve eleven years after transplantation. 
  • Application of the Seattle Heart Failure Model in ambulatory patients presented to an advanced heart failure therapeutics committee. 
  • Applying rigor and reproducibility standards to assay donor-derived cell-free DNA as a non-invasive method for detection of acute rejection and graft injury after heart transplantation. 
  • Aquaporin 4 blockade improves survival of murine heart allografts subjected to prolonged cold ischemia. 
  • Ascending aorta to main pulmonary artery fistula following orthotopic heart transplantation: successful percutaneous closure employing an Amplatzer Duct Occluder. 
  • Assessing Consequences of Intraaortic Balloon Counterpulsation Versus Left Ventricular Assist Devices at the Time of Heart Transplantation. 
  • Assessment of Heart Transplant Waitlist Time and Pre- and Post-transplant Failure: A Mixed Methods Approach. 
  • Association between primary graft dysfunction and acute kidney injury after orthotopic heart transplantation - a retrospective, observational cohort study. 
  • Association of Clinical Outcomes With Left Ventricular Assist Device Use by Bridge to Transplant or Destination Therapy Intent: The Multicenter Study of MagLev Technology in Patients Undergoing Mechanical Circulatory Support Therapy With HeartMate 3 (MOMENTUM 3) Randomized Clinical Trial. 
  • Association of tacrolimus time-to-therapeutic range on renal dysfunction and acute cellular rejection after orthotopic heart transplantation in a high use basiliximab population. 
  • Attitudes of patients with renal disease on xenotransplantation: A systematic review. 
  • B cell activating factor (BAFF) and a proliferation inducing ligand (APRIL) mediate CD40-independent help by memory CD4 T cells. 
  • B lymphocytes differentially influence acute and chronic allograft rejection in mice. 
  • BVS5000 support after cardiac transplantation. 
  • Barriers to cardiac transplantation in idiopathic dilated cardiomyopathy: the Washington, DC, Dilated Cardiomyopathy Study. 
  • Between Scylla and Charybdis: The choice of inotropic agent for decompensated heart failure. 
  • Biomarkers in Advanced Heart Failure: Implications for Managing Patients With Mechanical Circulatory Support and Cardiac Transplantation. 
  • Blood transfusions decrease the incidence of acute rejection in cardiac allograft recipients. 
  • Bloodless HeartMate 3 explantation and orthotopic heart transplant in a heart failure patient refusing blood products. 
  • Bloodless Orthotopic Heart Transplantation in a Jehovah's Witness. 
  • Bone marrow-derived AXL tyrosine kinase promotes mitogenic crosstalk and cardiac allograft vasculopathy. 
  • Brain death alters cardiopulmonary hemodynamics and impairs right ventricular power reserve against an elevation of pulmonary vascular resistance. 
  • Brain injury and ventricular dysfunction: insights into reversible heart failure. 
  • CARMAT Total Artificial Heart and the Quest to Improve Biventricular Mechanical Support. 
  • CD4 T Cell Help via B Cells Is Required for Lymphopenia-Induced CD8 T Cell Proliferation. 
  • CD68/CD31 immunohistochemistry double stain demonstrates increased accuracy in diagnosing pathologic antibody-mediated rejection in cardiac transplant patients. 
  • Cannulation strategy for centrifugal-flow ventricular assist device implantation late after arterial switch operation. 
  • Capnocytophagia canimorsus sepsis in an asplenic heart transplant candidate with a left ventricular assist system. 
  • Captopril and platelet-activating factor (PAF) antagonist prevent cardiac allograft vasculopathy in rats: role of endogenous PAF and PAF-like compounds. 
  • Captopril reduces graft coronary artery disease in a rat heterotopic transplant model. 
  • Captopril suppresses post-transplantation angiogenic activity in rat allograft coronary vessels. 
  • Cardiac Allograft Vasculopathy: A Formidable Foe. 
  • Cardiac Magnetic Resonance Feature Tracking Global Longitudinal Strain and Prognosis After Heart Transplantation. 
  • Cardiac allograft vasculopathy after heart transplantation: current prevention and treatment strategies. 
  • Cardiac allograft vasculopathy: A review. 
  • Cardiac dysfunction following brain death in children: prevalence, normalization, and transplantation. 
  • Cardiac transplantation at Duke University Medical Center. 
  • Cardiac transplantation following ACORN CorCap device implantation. 
  • Cardiac transplantation for older patients: Characteristics and outcomes in the septuagenarian population. 
  • Cardiac transplantation in a pediatric patient with systemic sclerosis. 
  • Cardiac transplantation in arrhythmogenic right ventricular dysplasia/cardiomyopathy. 
  • Cardiac xenografts between primate species provide evidence for the importance of the alpha-galactosyl determinant in hyperacute rejection. 
  • Cardiopulmonary transit time: Reinforcing the case for positron emission tomography after heart transplantation. 
  • Cardiothoracic Transplant Anesthesia: Selected Highlights: Part I-Lung Transplantation. 
  • Cardiothoracic Transplant Recipient Mycoplasma hominis: An Uncommon Infection with Probable Donor Transmission. 
  • Caregiver Health-Related Quality of Life, Burden, and Patient Outcomes in Ambulatory Advanced Heart Failure: A Report From REVIVAL. 
  • Case study: heart transplantation--increased incidence of acute rejection in female recipients. 
  • Case-control study of risk factors for the development of post-transplant lymphoproliferative disease in a pediatric heart transplant cohort. 
  • Cellular immunology markers postransplantation predictive of long-term graft outcome. 
  • Center variations in patient selection for simultaneous heart-kidney transplantation. 
  • Changes in United States heart allocation: A community energized to improve policy. 
  • Changes in Use of Left Ventricular Assist Devices as Bridge to Transplantation With New Heart Allocation Policy. 
  • Changing Demographics, Temporal Trends in Waitlist, and Posttransplant Outcomes After Heart Transplantation in the United States: Analysis of the UNOS Database 1991-2019. 
  • Characteristics of corneal xenograft rejection in a discordant species combination. 
  • Characteristics, Treatments, and Outcomes of Hospitalized Heart Failure Patients Stratified by Etiologies of Cardiomyopathy. 
  • Characterization of human anti-porcine "natural antibodies" recovered from ex vivo perfused hearts--predominance of IgM and IgG2. 
  • Chronic mechanical circulatory support for inotrope-dependent heart failure patients who are not transplant candidates: results of the INTrEPID Trial. 
  • Circulating mitochondria in organ donors promote allograft rejection. 
  • Clinical Outcomes and Quality of Life With an Ambulatory Counterpulsation Pump in Advanced Heart Failure Patients: Results of the Multicenter Feasibility Trial. 
  • Clinical outcome of interval cadaveric renal transplantation in cardiac allograft recipients. 
  • Clinical outcomes after implantation of a centrifugal flow left ventricular assist device and concurrent cardiac valve procedures. 
  • Clinical outcomes and healthcare expenditures in the real world with left ventricular assist devices - The CLEAR-LVAD study. 
  • Colonic Crohn Disease After Cardiac Transplantation: Case Report and Literature Review. 
  • Combination anti-CD2 and anti-CD3 monoclonal antibodies induce tolerance while altering interleukin-2, interleukin-4, tumor necrosis factor, and transforming growth factor-beta production. 
  • Combined total lymphoid irradiation and cyclosporine promote xenograft survival. 
  • Commentary: Shunted single-ventricle neonatal ventricular-assist device support: Are we nearing a consensus strategy? 
  • Comparison of 2-Year Outcomes of Extended Criteria Cardiac Transplantation Versus Destination Left Ventricular Assist Device Therapy Using Continuous Flow. 
  • Comparison of PRA-STAT, sHLA-EIA, and anti-human globulin-panel reactive antibody to identify alloreactivity in pretransplantation sera of heart transplant recipients: correlation to rejection and posttransplantation coronary artery disease. 
  • Comparison of right ventricle-pulmonary artery shunt position in the Single Ventricle Reconstruction trial. 
  • Complete atrioventricular cardiac transplantation: improved performance compared with the standard technique. 
  • Confusion, Headache, and Constitutional Symptoms in a Heart Transplant Recipient. 
  • Consensus conference report: maximizing use of organs recovered from the cadaver donor: cardiac recommendations, March 28-29, 2001, Crystal City, Va. 
  • Contemporary Nationwide Heart Transplantation and Left Ventricular Assist Device Outcomes in Patients with Histories of Bariatric Surgery. 
  • Continuous complement (C) inhibition using soluble C receptor type 1 (sCR1): effect on hyperacute rejection (HAR) of pig-to-primate cardiac xenografts. 
  • Controversies and Challenges of Ventricular Assist Device Therapy. 
  • Coronary Microcirculatory Dysfunction and Acute Cellular Rejection After Heart Transplantation. 
  • Coronary revascularization rather than cardiac transplantation for chronic ischemic cardiomyopathy. 
  • Cost of ventricular assist devices: can we afford the progress? 
  • Creation of a quantitative recipient risk index for mortality prediction after cardiac transplantation (IMPACT). 
  • Critically appraising the 2018 United Network for Organ Sharing donor allocation policy: adding life boats or rearranging the deck chairs? 
  • Cultured thymus tissue implantation promotes donor-specific tolerance to allogeneic heart transplants. 
  • Cyclosporine nephrotoxicity in cardiac allograft patients--a seven-year follow-up. 
  • Cytokine genotypes in kidney, heart, and lung recipients: consequences for acute and chronic rejection. 
  • Cytotoxic T lymphocyte antigen 4 (CTLA4) blockade accelerates the acute rejection of cardiac allografts in CD28-deficient mice: CTLA4 can function independently of CD28. 
  • Decline of Increased Risk Donor Offers on Waitlist Survival in Heart Transplantation. 
  • Decline of increased risk donor offers increases waitlist mortality in paediatric heart transplantation. 
  • Decreased fibrinolytic activity in porcine-to-primate cardiac xenotransplantation. 
  • Decreasing Wait List Mortality for Heart Transplantation in the Eurotransplant Network. 
  • Defining and refining heart failure risk stratification to optimize patient selection for cardiac transplantation. 
  • Delayed cardiac xenograft rejection in a pig-to-baboon model treated with a tolerance-inducing regimen and donor bone marrow infusion. 
  • Depletion-Resistant CD4 T Cells Enhance Thymopoiesis During Lymphopenia. 
  • Depressive symptoms, physical activity, and clinical events: The ADAPT prospective pilot study. 
  • Development of a quantitative donor risk index to predict short-term mortality in orthotopic heart transplantation. 
  • Developmental exposure to noninherited maternal antigens induces CD4+ T regulatory cells: relevance to mechanism of heart allograft tolerance. 
  • Different roles for matrix metalloproteinase-2 and matrix metalloproteinase-9 in the pathogenesis of cardiac allograft rejection. 
  • Differential effects of donor-specific alloantibody. 
  • Differential inflammatory responses of the native left and right ventricle associated with donor heart preservation. 
  • Differential localization of allograft nitric oxide synthesis: comparison of liver and heart transplantation in the rat model. 
  • Diltiazem preserves direct vasodilator response but fails to suppress intimal proliferation in rat allograft coronary artery disease. 
  • Discordant Perceptions of Prognosis and Treatment Options Between Physicians and Patients With Advanced Heart Failure. 
  • Divergent mitochondrial biogenesis responses in human cardiomyopathy. 
  • Dobutamine stress echocardiography: experience in pediatric heart transplant recipients. 
  • Does Survival on the Heart Transplant Waiting List Depend on the Underlying Heart Disease? 
  • Does competition for transplantable hearts encourage 'gaming' of the waiting list? 
  • Does recipient age impact functional outcomes of orthotopic heart transplantation? 
  • Donation After Circulatory Death in Heart Transplantation: History, Outcomes, Clinical Challenges, and Opportunities to Expand the Donor Pool. 
  • Donation after circulatory determination of death in heart transplant: impact on current and future allocation policy. 
  • Donor and recipient age matching in heart transplantation: analysis of the UNOS Registry. 
  • Donor fraction cell-free DNA and rejection in adult and pediatric heart transplantation. 
  • Donor predictors of allograft use and recipient outcomes after heart transplantation. 
  • Dose-dependent association between amiodarone and severe primary graft dysfunction in orthotopic heart transplantation. 
  • Dual Procurement of Lung and Heart Allografts Does Not Negatively Affect Lung Transplant Outcomes. 
  • Durable mechanical circulatory support devices. 
  • Dynamic regulation of phosphoinositide 3-kinase-gamma activity and beta-adrenergic receptor trafficking in end-stage human heart failure. 
  • ECMO as a Bridge to Left Ventricular Assist Device or Heart Transplantation. 
  • EXPANDing the Donor Pool: Quantifying the Potential Impact of a Portable Organ-Care System for Expanded Criteria Heart Donation. 
  • Early and late forms of cyclosporine nephrotoxicity: studies in cardiac transplant recipients. 
  • Economic evaluation of everolimus vs. azathioprine at one year after de novo heart transplantation. 
  • Editorial Commentary: Determining the cost-effectiveness of mechanical circulatory support. 
  • Editorial commentary: renal failure after cardiac transplantation: of bravery, wisdom and honesty. 
  • Effect of Socioeconomic Status on Patients Supported with Contemporary Left Ventricular Assist Devices. 
  • Effect of continuous complement inhibition using soluble complement receptor type 1 on survival of pig-to-primate cardiac xenografts. 
  • Effect of sensitization in US heart transplant recipients bridged with a ventricular assist device: update in a modern cohort. 
  • Effect of soluble complement receptor type 1 on natural antibody levels during xenograft rejection. 
  • Effect of surrogate tolerogenesis on the vascular rejection of pig heart xenografts. 
  • Effectiveness of percutaneous coronary intervention in cardiac allograft vasculopathy. 
  • Effects of donor splenocytes treated with mitomycin C on rat hepatic, cardiac, and intestinal allografts. 
  • Effects of immunosuppression and pretransplant splenectomy in newborn cardiac xenograft survival. 
  • Effects of nitric oxide after cardiac transplantation in the setting of recipient pulmonary hypertension. 
  • Effects of pretransplant splenectomy and immunosuppression of humoral immunity in a pig-to-newborn goat cardiac xenograft model. 
  • Efficacy of signal-averaged electrocardiography in the young orthotopic heart transplant patient to detect allograft rejection. 
  • Electrocardiographic characteristics of potential organ donors and associations with cardiac allograft use. 
  • Electron-beam computed tomography in the assessment of coronary artery disease after heart transplantation. 
  • Elevated Cardiac Troponin I in Preservation Solution Is Associated With Primary Graft Dysfunction. 
  • Elevated donor hemoglobin A1c does not impair early survival in cardiac transplant recipients. 
  • Elevated uric acid levels predict allograft vasculopathy in cardiac transplant recipients. 
  • Endomyocardial Biopsy Characterization of Heart Failure With Preserved Ejection Fraction and Prevalence of Cardiac Amyloidosis. 
  • Endothelial Stromal PD-L1 (Programmed Death Ligand 1) Modulates CD8+ T-Cell Infiltration After Heart Transplantation. 
  • Endurance exercise in the presence of heart disease. 
  • Enrollment in Heart Failure Clinical Trials: Insights Into Which Entry Criteria Exclude Patients. 
  • Essential role for Smad3 in regulating MCP-1 expression and vascular inflammation. 
  • Evaluation of Racial and Ethnic Disparities in Cardiac Transplantation. 
  • Evaluation of early postoperative results after bicaval versus standard cardiac transplantation and review of the literature. 
  • Ex Vivo Delivery of Viral Vectors by Organ Perfusion for Cardiac Transplantation Gene Therapy. 
  • Ex Vivo Gene Delivery to Porcine Cardiac Allografts Using a Myocardial-Enhanced Adeno-Associated Viral Vector. 
  • Ex vivo adenovirus-mediated gene transfer to the adult rat heart. 
  • Ex vivo characterization of human anti-porcine hyperacute cardiac rejection. 
  • Examination of the mechanisms responsible for tolerance induction after intrathymic inoculation of allogeneic bone marrow. 
  • Examining the Incidence and Presentation of Melanoma in the Cardiothoracic Transplant Population. 
  • Exception-Status Listing: A Critical Pathway to Heart Transplantation for Adults With Congenital Heart Diseases. 
  • Exploring differences between patients who accept, decline, and are deemed ineligible for left ventricular assist device implantation as destination therapy. 
  • Expression of heme oxygenase-1 can determine cardiac xenograft survival. 
  • Extended mechanical circulatory support with a continuous-flow rotary left ventricular assist device. 
  • Extracorporeal membrane oxygenation support and post-heart transplant outcomes among United States adults. 
  • First successful bridge to cardiac transplantation using direct mechanical ventricular actuation. 
  • Fontan-associated protein-losing enteropathy and heart transplant: A Pediatric Heart Transplant Study analysis. 
  • Frailty in the End-Stage Lung Disease or Heart Failure Patient: Implications for the Perioperative Transplant Clinician. 
  • Fusion of aortic valve commissures in patients supported by a continuous axial flow left ventricular assist device. 
  • Gene expression analysis of cardiovascular diseases: novel insights into biology and clinical applications. 
  • Gene transfer and expression in rat cardiac transplants. 
  • Genetic cardiomyopathies and clinical implications in heart transplant recipients: An opportunity for missed diagnoses. 
  • Genomic characterization of recurrent mold infections in thoracic transplant recipients. 
  • Global gene expression profiling of end-stage dilated cardiomyopathy using a human cardiovascular-based cDNA microarray. 
  • Graft vascular disease after cardiac transplantation and its relationship to mean acute rejection score. 
  • H2-DMalpha(-/-) mice show the importance of major histocompatibility complex-bound peptide in cardiac allograft rejection. 
  • HCV Positive Allograft Use in Heart Transplant: A Silver Lining to an Epidemic. 
  • HLA histocompatibility affects cardiac transplant rejection and may provide one basis for organ allocation. 
  • Happy 50th Birthday, Cardiac Transplantation: Happy 5th Birthday, JACC: Heart Failure. 
  • Healthcare Resource Use and Cost Implications in the MOMENTUM 3 Long-Term Outcome Study. 
  • Heart Transplantation After HeartMate 3 Use Shortens Hospitalization but Might Impose Increased Risk of Rejection. 
  • Heart Transplantation Survival Outcomes of HIV Positive and Negative Recipients. 
  • Heart Transplantation Survival and the Use of Traumatically Brain-Injured Donors: UNOS Registry Propensity-Matched Analysis. 
  • Heart Transplantation and Mechanical Circulatory Support in Adults with Congenital Heart Disease. 
  • Heart Transplantation: An In-Depth Survival Analysis. 
  • Heart transplantation for a patient with Kearns-Sayre syndrome and end-stage heart failure. 
  • Heart transplantation for adults with congenital heart disease: analysis of the United network for organ sharing database. 
  • Heart transplantation in neonates and in children. 
  • Heart xenograft survival with chimeric pig donors and modest immune suppression. 
  • Hematopoietic stem cell dose correlates with the speed of immune reconstitution after stem cell transplantation. 
  • Hemodynamic and inotropic effects of milrinone after heart transplantation in the setting of recipient pulmonary hypertension. 
  • Heparan sulfate is a plasma biomarker of acute cellular allograft rejection. 
  • Heparin-induced thrombocytopenia in left ventricular assist device bridge-to-transplant patients. 
  • Hepatitis B core antibody-positive donors in cardiac transplantation: a single-center experience. 
  • High early event rates in patients with questionable eligibility for advanced heart failure therapies: Results from the Medical Arm of Mechanically Assisted Circulatory Support (Medamacs) Registry. 
  • Highlights of the 2010 scientific sessions of the Heart Failure Society of America, San Diego, California, September 12-15, 2010. 
  • Human pathologic correlation with PET in ischemic and nonischemic cardiomyopathy. 
  • Humoral responses to pig-to-baboon cardiac transplantation: implications for the pathogenesis and treatment of acute vascular rejection and for accommodation. 
  • Hypercholesterolemia is common after pediatric heart transplantation: initial experience with pravastatin. 
  • IFI16-STING-NF-κB signaling controls exogenous mitochondrion-induced endothelial activation. 
  • INTERMACS: interval analysis of registry data. 
  • Identification of poorly performing transplant centers using the UNOS center-specific data. 
  • IgG is a prominent component of cynomolgus antiporcine natural xenoantibody. 
  • Imaging for Temporary Mechanical Circulatory Support Devices. 
  • Immunity to MHC class I antigen after direct DNA transfer into skeletal muscle. 
  • Immunoglobulin prevents complement-mediated hyperacute rejection in swine-to-primate xenotransplantation. 
  • Immunosuppressive effects of an HLA class I-derived peptide in a rat cardiac allograft model. 
  • Impact of ABO compatibility on outcomes after heart transplantation in a national cohort during the past decade. 
  • Impact of Bridge to Transplantation With Continuous-Flow Left Ventricular Assist Devices on Posttransplantation Mortality. 
  • Impact of Cardiovascular Magnetic Resonance Imaging on Identifying the Etiology of Cardiomyopathy in Patients Undergoing Cardiac Transplantation. 
  • Impact of Induction Immunosuppression on Post-Transplant Outcomes of Patients Bridged with Contemporary Left Ventricular Assist Devices. 
  • Impact of Leukocyte Function-Associated Antigen-1 Blockade on Endogenous Allospecific T Cells to Multiple Minor Histocompatibility Antigen Mismatched Cardiac Allograft. 
  • Impact of Obesity on Heart Transplantation Outcomes. 
  • Impact of Obesity on Ventricular Assist Device Outcomes. 
  • Impact of donor cardiac arrest on heart transplantation. 
  • Impact of donor-to-recipient weight ratio on survival after heart transplantation: analysis of the United Network for Organ Sharing Database. 
  • Impact of left ventricular assist device bridging on posttransplant outcomes. 
  • Impact of recipient body mass index on organ allocation and mortality in orthotopic heart transplantation. 
  • Impact of the 2018 UNOS Heart Transplant Policy Changes on Patient Outcomes. 
  • Impact of the New Pulmonary Hypertension Definition on Heart Transplant Outcomes: Expanding the Hemodynamic Risk Profile. 
  • Impact of the heart transplant allocation policy change on inpatient cost of index hospitalization. 
  • Impact of the new heart allocation policy on patients with restrictive, hypertrophic, or congenital cardiomyopathies. 
  • Impaired insulin response after oral but not intravenous glucose in heart- and liver-transplant recipients. 
  • Implantation of a HeartMate 3 ventricular assist device in a 21-kg pediatric patient with Fontan failure. 
  • Improved Detection of Cardiac Allograft Vasculopathy: A Multi-Institutional Analysis of Functional Parameters in Pediatric Heart Transplant Recipients. 
  • Improved Outcomes in Severe Primary Graft Dysfunction After Heart Transplantation Following Donation After Circulatory Death Compared With Donation After Brain Death. 
  • In-Hospital Outcomes in Pregnancy After Heart Transplantation. 
  • Incidence and Impact of On-Cardiopulmonary Bypass Vasoplegia During Heart Transplantation. 
  • Incidence and early outcomes associated with pre-transplant antivimentin antibodies in the cardiac transplantation population. 
  • Incidence and impact of primary graft dysfunction in adult heart transplant recipients: A systematic review and meta-analysis. 
  • Incidence and prognosis of COVID-19 amongst heart transplant recipients: a systematic review and meta-analysis. 
  • Increase in nuclear cell-free DNA is associated with major adverse events in adult and pediatric heart transplant recipients. 
  • Increased Opportunities for Transplantation for Women in the New Heart Allocation System. 
  • Increased mortality at low-volume orthotopic heart transplantation centers: should current standards change? 
  • Increasing the United States heart transplant donor pool with donation after circulatory death. 
  • Incremental and independent value of cardiopulmonary exercise test measures and the Seattle Heart Failure Model for prediction of risk in patients with heart failure. 
  • Indications for and outcomes of therapeutic plasma exchange after cardiac transplantation: A single center retrospective study. 
  • Inducible nitric oxide synthase promotes cytokine expression in cardiac allografts but is not required for efficient rejection. 
  • Induction of donor-specific tolerance to heart transplantation: From concept to clinical translation. 
  • Induction therapy with basiliximab allows delayed initiation of cyclosporine and preserves renal function after cardiac transplantation. 
  • Infectious complications in extended criteria heart transplantation. 
  • Influence of donor brain death duration on outcomes following heart transplantation: A United Network for Organ Sharing Registry analysis. 
  • Influence of gender on allograft rejection in a rat heart transplant model. 
  • Influence of pretransplant panel-reactive antibody on outcomes in 8,160 heart transplant recipients in recent era. 
  • Inhaled Iloprost Versus Epoprostenol in Heart Transplant Recipients. 
  • Initial Experience of Left Ventricular Assist Device Support for Adult Patients with Transposition of the Great Vessels. 
  • Innate Functions of Dendritic Cell Subsets in Cardiac Allograft Tolerance. 
  • Innovations in Heart Transplantation: A Review. 
  • Institutional volume and the effect of recipient risk on short-term mortality after orthotopic heart transplant. 
  • Insurance and education predict long-term survival after orthotopic heart transplantation in the United States. 
  • Intensity and focus of heart failure disease management after hospital discharge. 
  • Interleukin-27 promotes CD8+ T cell reconstitution following antibody-mediated lymphoablation. 
  • Intermediate-term mortality and cardiac transplantation in infants with single-ventricle lesions: risk factors and their interaction with shunt type. 
  • International Society for Heart and Lung Transplantation consensus statement for the standardization of bronchoalveolar lavage in lung transplantation. 
  • Intracardiac transplantation of a mixed population of bone marrow cells improves both regional systolic contractility and diastolic relaxation. 
  • Intragraft CD11b(+) IDO(+) cells mediate cardiac allograft tolerance by ECDI-fixed donor splenocyte infusions. 
  • Intraoperative Administration of 4-Factor Prothrombin Complex Concentrate Reduces Blood Requirements in Cardiac Transplantation. 
  • Intrathymic injection of donor alloantigens induces donor-specific vascularized allograft tolerance without immunosuppression. 
  • Intravenous milrinone in cardiac surgery. 
  • Invited commentary. 
  • Is it time for the United States to engage in heart transplantation using donation after circulatory death? 
  • Is there a role for upper-extremity intra-aortic balloon counterpulsation as a bridge-to-recovery or a bridge-to-transplant in the treatment of end-stage heart failure? 
  • Lead one ratio in left bundle branch block predicts poor cardiac resynchronization therapy response. 
  • Left ventricular assist device destination therapy versus extended criteria cardiac transplant. 
  • Less Is More in Post Pediatric Heart Transplant Care. 
  • Lessons learned from 119 consecutive cardiac transplants for pediatric and congenital heart disease. 
  • Listing criteria for heart transplantation: International Society for Heart and Lung Transplantation guidelines for the care of cardiac transplant candidates--2006. 
  • Long-term outcomes and management of the heart transplant recipient. 
  • Long-term outcomes of simultaneous heart and kidney transplantation in pediatric recipients. 
  • Lovastatin therapy for hypercholesterolemia in cardiac transplant recipients. 
  • Low lead one ratio predicts clinical outcomes in left bundle branch block. 
  • Low operative mortality with implantation of a continuous-flow left ventricular assist device and impact of concurrent cardiac procedures. 
  • Low thromboembolism and pump thrombosis with the HeartMate II left ventricular assist device: analysis of outpatient anti-coagulation. 
  • MELD-XI Score Predicts Early Mortality in Patients After Heart Transplantation. 
  • Management of 239 patients with hypoplastic left heart syndrome and related malformations from 1993 to 2007. 
  • Management of biliary complications after heart transplantation. 
  • Management of children undergoing cardiac transplantation with high Panel Reactive Antibodies. 
  • Management of primary graft failure after heart transplantation: Preoperative risks, perioperative events, and postoperative decisions. 
  • Managing VAD Complications: Our Growth Industry. 
  • Marginal Donor Use in Patients Undergoing Heart Transplantation With Left Ventricular Assist Device Explantation. 
  • Marginal cardiac allografts do not have increased primary graft dysfunction in alternate list transplantation. 
  • Marital status improves survival after orthotopic heart transplantation. 
  • Mechanical Circulatory Support Device Utilization and Heart Transplant Waitlist Outcomes in Patients With Restrictive and Hypertrophic Cardiomyopathy. 
  • Mechanical ventilation at the time of heart transplantation and associations with clinical outcomes. 
  • Mechanical ventricular support lowers pulmonary vascular resistance in a patient with congential heart disease. 
  • Mechanisms of tolerance induced by PG490-88 in a bone marrow transplantation model. 
  • Mechanisms of transplant right ventricular dysfunction. 
  • Mechanistic Insights into Sympathetic Neuronal Regeneration: Multitracer Molecular Imaging of Catecholamine Handling After Cardiac Transplantation. 
  • Migration of Intraaortic Balloon Pump Placed Via the Axillary Artery. 
  • Mitigating the Impact of Using Female Donor Hearts in Male Recipients Using BMI Difference. 
  • Multicenter Registry Using Propensity Score Analysis to Compare a Novel Transport/Preservation System to Traditional Means on Postoperative Hospital Outcomes and Costs for Heart Transplant Patients. 
  • Multidisciplinary Stroke Pathway for Children Supported With Ventricular Assist Devices. 
  • Myocardial Damage Detected by Late Gadolinium Enhancement Cardiac Magnetic Resonance Is Uncommon in Peripartum Cardiomyopathy. 
  • Myocardial Fibrosis and Prognosis in Heart Transplant Recipients. 
  • Myocardial Involvement in Patients With Histologically Diagnosed Cardiac Sarcoidosis: A Systematic Review and Meta-Analysis of Gross Pathological Images From Autopsy or Cardiac Transplantation Cases. 
  • Myocardial acoustics in pediatric allograft rejection. 
  • Myocardial performance after graft preservation and subsequent cardiac transplantation from brain-dead donors. 
  • Myocardial scar in sarcoidosis by 12-lead ECG and pathology. 
  • National decline in donor heart utilization with regional variability: 1995-2010. 
  • Natural antipig xenoantibody is absent in neonatal human serum. 
  • Neointimal inflammation and adventitial angiogenesis correlate with severity of cardiac allograft vasculopathy in pediatric recipients. 
  • Neurocognitive assessments in advanced heart failure patients receiving continuous-flow left ventricular assist devices. 
  • Neurocognitive function in destination therapy patients receiving continuous-flow vs pulsatile-flow left ventricular assist device support. 
  • New developments in cardiovascular adrenergic receptor pharmacology: molecular mechanisms and clinical relevance. 
  • New method of measuring coronary diameter by electron-beam computed tomographic angiography using adjusted thresholds determined by calibration with aortic opacity. 
  • New-onset diabetes after pediatric heart transplantation: A review of the Pediatric Heart Transplant Study. 
  • Newborn discordant cardiac xenotransplantation in primates: a model of natural antibody depletion. 
  • Nonadherence is associated with late rejection in pediatric heart transplant recipients. 
  • Noteworthy Literature Published in 2018 for Thoracic Organ Transplantation. 
  • Ocular manifestations of patients receiving heart transplants: a single-center experience of 311 consecutive cases. 
  • Omega-3 fatty acids in cardiac biopsies from heart transplantation patients: correlation with erythrocytes and response to supplementation. 
  • One-and-done: Do left ventricular assist device patients on the transplant list really need frequent right heart catheterization assessments for pulmonary hypertension? 
  • Organ allocation around the world: insights from the ISHLT International Registry for Heart and Lung Transplantation. 
  • Orotic acid improves left ventricular recovery four days after heterotopic transplantation. 
  • Outcomes after percutaneous coronary artery revascularization procedures for cardiac allograft vasculopathy in pediatric heart transplant recipients: A multi-institutional study. 
  • Outcomes and predictors of recovery in acute-onset cardiomyopathy: A single-center experience of patients undergoing endomyocardial biopsy for new heart failure. 
  • Outcomes in Patients Bridged With Univentricular and Biventricular Devices in the Modern Era of Heart Transplantation. 
  • Outcomes in bicaval versus biatrial techniques in heart transplantation: an analysis of the UNOS database. 
  • Outcomes of cholecystectomy in US heart transplant recipients. 
  • Outcomes of left ventricular assist device implantation as destination therapy in the post-REMATCH era: implications for patient selection. 
  • Outcomes of transplantation using organs from a donor infected with Klebsiella pneumoniae carbapenemase (KPC)-producing K. pneumoniae. 
  • Outcomes with ambulatory advanced heart failure from the Medical Arm of Mechanically Assisted Circulatory Support (MedaMACS) Registry. 
  • Outcomes with an alternate list strategy for heart transplantation. 
  • Overcoming Chronic Rejection-Can it B? 
  • PD-1 and PD-L1 expression in cardiac transplantation. 
  • Partial Heart Transplantation in Adult Cardiac Surgery. 
  • Partial heart transplantation can ameliorate donor organ utilization. 
  • Partial heart transplantation for pediatric heart valve dysfunction: A clinical trial protocol. 
  • Patient selection for mechanical circulatory support. 
  • Patterns of de novo allo B cells and antibody formation in chronic cardiac allograft rejection after alemtuzumab treatment. 
  • Pericardial Adipose Tissue Volume and Left Ventricular Assist Device-Associated Outcomes. 
  • Peripartum cardiomyopathy: a review of the literature. 
  • Peripheral blood allogeneic microchimerism in lung and cardiac allograft recipients. 
  • Permanent survival of fully MHC-mismatched islet allografts by targeting a single chemokine receptor pathway. 
  • Pharmacologic reduction of pretransplantation pulmonary vascular resistance predicts outcome after pediatric heart transplantation. 
  • Phenotype of infiltrating cells in an ex vivo model of human antiporcine hyperacute cardiac xenograft rejection. 
  • Photopheresis for the prevention of rejection in cardiac transplantation. Photopheresis Transplantation Study Group. 
  • Planned right ventricular support for combined heart-liver transplantation. 
  • Planning helps, behavioral disengagement does not: coping and depression in the spouses of heart transplant candidates. 
  • Plasma kallikrein predicts primary graft dysfunction after heart transplant. 
  • Plastic bronchitis: resolution after heart transplantation. 
  • Platelet-derived or soluble CD154 induces vascularized allograft rejection independent of cell-bound CD154. 
  • Post-cardiac transplant survival after support with a continuous-flow left ventricular assist device: impact of duration of left ventricular assist device support and other variables. 
  • Post-operative heparin may not be required for transitioning patients with a HeartMate II left ventricular assist system to long-term warfarin therapy. 
  • Postoperative management of heart transplantation patients. 
  • Potential for donation after circulatory death heart transplantation in the United States: Retrospective analysis of a limited UNOS dataset. 
  • Practice variation in the diagnosis of acute rejection among pediatric heart transplant centers: An analysis of the pediatric heart transplant society (PHTS) registry. 
  • Pre-transplant analysis of accommodation in donor pigs. 
  • Predictors of disease progression in pediatric dilated cardiomyopathy. 
  • Predictors of outcome of myocarditis. 
  • Preemptive donor apoptotic cell infusions induce IFN-γ-producing myeloid-derived suppressor cells for cardiac allograft protection. 
  • Pretransplant antithymocyte globulin has increased efficacy in controlling donor-reactive memory T cells in mice. 
  • Prevention of hyperacute xenograft rejection by intravenous immunoglobulin. 
  • Prevention of ischemically induced neointimal hyperplasia using ex vivo antisense oligodeoxynucleotides. 
  • Prevention of post-transplant cardiovascular disease--report and recommendations of an ad hoc group. 
  • Primary Graft Dysfunction after Heart Transplantation - Unravelling the Enigma. 
  • Primary graft dysfunction after heart transplantation: Incidence, trends, and associated risk factors. 
  • Primary vascularization of the graft determines the immunodominance of murine minor H antigens during organ transplantation. 
  • Prognostic value of left ventricular apical tissue removed for HeartMate II left ventricular assist device placement. 
  • Proinflammatory actions of thromboxane receptors to enhance cellular immune responses. 
  • Prolonged discordant cardiac xenograft survival in newborn recipients. 
  • Prolonged discordant xenograft survival and delayed xenograft rejection in a pig-to-baboon orthotopic cardiac xenograft model. 
  • Prolonged heart xenograft survival using combined total lymphoid irradiation and cyclosporine. 
  • Prolonged survival of class II transactivator-deficient cardiac allografts. 
  • Prolonged survival of pig cardiac xenografts in unmodified newborn baboons. 
  • Prostaglandin E1-Induced Periostitis and Reversibility with Discontinuation. 
  • Proteomic profiling identifies CLEC4C expression as a novel biomarker of primary graft dysfunction after heart transplantation. 
  • Psychosocial considerations in the assessment of hand transplant candidates: A single-center experience and brief literature review. 
  • Pulmonary hypertension and risk of death in cardiomyopathy: patients with myocarditis are at higher risk. 
  • Pulmonary mucormycosis: radiologic findings in 32 cases. 
  • Pulmonary vascular impedance and recipient chronic pulmonary hypertension following cardiac transplantation. 
  • Quantitative cardiac magnetic resonance T2 imaging offers ability to non-invasively predict acute allograft rejection in children. 
  • Racial and socioeconomic disparities in pediatric heart transplant outcomes in the era of anti-thymocyte globulin induction. 
  • Rapamycin Interferes With Postdepletion Regulatory T Cell Homeostasis and Enhances DSA Formation Corrected by CTLA4-Ig. 
  • Rationing failure. The ethical lessons of the retransplantation of scarce vital organs. 
  • Reassessing Recipient Mortality Under the New Heart Allocation System: An Updated UNOS Registry Analysis. 
  • Recent advances in porcine cardiac xenotransplantation: from aortic valve replacement to heart transplantation. 
  • Receptor tyrosine kinase MerTK suppresses an allogenic type I IFN response to promote transplant tolerance. 
  • Recurrence of cardiac sarcoidosis in a heart transplant recipient. 
  • Rejection of canine cardiac allografts. 
  • Relationship Between Electrical and Mechanical Dyssynchrony and Outcomes Among Patients Undergoing Cardiac Resynchronization Therapy. 
  • Relationship between coping and depression in heart transplant candidates and their spouses. 
  • Relationship between donor fraction cell-free DNA and clinical rejection in heart transplantation. 
  • Relationship of ventricular assist device support duration with pediatric heart transplant outcomes. 
  • Reliability and construct validity of PROMIS® measures for patients with heart failure who undergo heart transplant. 
  • Reliability of echocardiographic measurements of left ventricular systolic function in potential pediatric heart transplant donors. 
  • Reliability of transthoracic echocardiogram interpretation in potential adult heart transplant donors. 
  • Renal Outcomes in Patients Bridged to Heart Transplant With a Left Ventricular Assist Device. 
  • Renal failure in cardiac transplantation. 
  • Reoperative sternotomy is associated with increased mortality after heart transplantation. 
  • Repair of congenital heart disease: a primer--Part 2. 
  • Reply from authors: Heart donor brain death duration-external validation from across the pond. 
  • Reply: Heart Transplant Allocation Under New Policy: Perceived Risk and Gaming the System. 
  • Report From the American Society of Transplantation Conference on Donor Heart Selection in Adult Cardiac Transplantation in the United States. 
  • Report from a consensus conference on antibody-mediated rejection in heart transplantation. 
  • Report from a consensus conference on primary graft dysfunction after cardiac transplantation. 
  • Report from a forum on US heart allocation policy. 
  • Response by Shah et al to Letter Regarding Article, "Cell-Free DNA to Detect Heart Allograft Acute Rejection". 
  • Response by Truby and Topkara to Letter Regarding Article, "Impact of Bridge to Transplantation With Continuous-Flow Left Ventricular Assist Devices on Posttransplantation Mortality: A Propensity-Matched Analysis of the United Network of Organ Sharing Database". 
  • Results of the post-U.S. Food and Drug Administration-approval study with a continuous flow left ventricular assist device as a bridge to heart transplantation: a prospective study using the INTERMACS (Interagency Registry for Mechanically Assisted Circulatory Support). 
  • Reversal of severe late left ventricular failure after pediatric heart transplantation and possible role of plasmapheresis. 
  • Rho kinase promotes alloimmune responses by regulating the proliferation and structure of T cells. 
  • Right ventricle-dominant cardiac sarcoidosis with sparing of the left ventricle. 
  • Right ventricular adaptation to increased afterload after orthotopic cardiac transplantation in the setting of recipient chronic pulmonary hypertension. 
  • Right ventricular dysfunction after cardiac transplantation: primarily related to status of donor heart. 
  • Right ventricular dysfunction in the brain-dead heart-beating organ donor. 
  • Right ventricular function in orthotopic total atrioventricular heart transplantation. 
  • Rinse, Wash, Repeat: The Evolution of the UNOS Heart Transplant Allocation System. 
  • Risk assessment for continuous flow left ventricular assist devices: does the destination therapy risk score work? An analysis of over 1,000 patients. 
  • Risk of anaphylaxis from aprotinin re-exposure during LVAD removal and heart transplantation. 
  • Risk of severe primary graft dysfunction in patients bridged to heart transplantation with continuous-flow left ventricular assist devices. 
  • Risk score derived from pre-operative data analysis predicts the need for biventricular mechanical circulatory support. 
  • Risk versus reward: total joint arthroplasty outcomes after various solid organ transplantations. 
  • Role of C1q complement fixing antibody assay in therapeutic plasma exchange management of pediatric cardiac antibody mediated rejection. 
  • Role of Toll-like receptor-driven innate immunity in thoracic organ transplantation. 
  • Role of endomyocardial biopsy in rejection surveillance after heart transplantation in neonates and children. 
  • Routine performance of endomyocardial biopsy decreases the incidence of orthotopic heart transplant for myocarditis. 
  • Sacubitril/Valsartan in Advanced Heart Failure With Reduced Ejection Fraction: Rationale and Design of the LIFE Trial. 
  • Safety and Utility of Cardiopulmonary Exercise Testing in Arrhythmogenic Right Ventricular Cardiomyopathy/Dysplasia. 
  • Safety and prognostic value of regadenoson stress cardiovascular magnetic resonance imaging in heart transplant recipients. 
  • Same bridge, new destinations rethinking paradigms for mechanical cardiac support in heart failure. 
  • Semiquantitative measurement of cytokine messenger RNA in endomyocardium and peripheral blood mononuclear cells from human heart transplant recipients. 
  • Serum vascular endothelial growth factor as a surveillance marker for cellular rejection in pediatric cardiac transplantation. 
  • Sex Differences in Mortality Based on United Network for Organ Sharing Status While Awaiting Heart Transplantation. 
  • Sex-Related Differences in Use and Outcomes of Left Ventricular Assist Devices as Bridge to Transplantation. 
  • Sex-Specific Differences in Heart Failure: Pathophysiology, Risk Factors, Management, and Outcomes. 
  • Solid organ transplantation after treatment for childhood cancer: a retrospective cohort analysis from the Childhood Cancer Survivor Study. 
  • Solid organ transplantation in primary mitochondrial disease: Proceed with caution. 
  • Spectrum of humoral rejection after pediatric heart transplantation. 
  • Stage 1 hybrid palliation for hypoplastic left heart syndrome--assessment of contemporary patterns of use: an analysis of The Society of Thoracic Surgeons Congenital Heart Surgery Database. 
  • State-Level Variation in Waitlist Mortality and Transplant Outcomes Among Patients Listed for Heart Transplantation in the US From 2011 to 2016. 
  • Statement regarding the pre and post market assessment of durable, implantable ventricular assist devices in the United States. 
  • Statement regarding the pre and post market assessment of durable, implantable ventricular assist devices in the United States: executive summary. 
  • Striking a Balance in Simultaneous Heart Kidney Transplant: Optimizing Outcomes for All Wait-Listed Patients. 
  • Successful treatment of Trichosporon mucoides infection with fluconazole in a heart and kidney transplant recipient. 
  • Sudden cardiac death after heart transplantation: can ICD prevent SCD? 
  • Suppression of hepatic allograft rejection in the rat by mitomycin C-treated donor splenocytes: analysis of the immune status. 
  • Surgical treatments for advanced heart failure. 
  • Surrogate markers for late cardiac allograft survival. 
  • Surrogate tolerogenesis: possible pretransplant induction of accommodation of pig xenografts. 
  • Survival After Orthotopic Heart Transplantation in Patients Undergoing Bridge to Transplantation With the HeartWare HVAD Versus the Heartmate II. 
  • Survival of patients removed from the heart transplant waiting list. 
  • Survival to Stage II with Ventricular Dysfunction: Secondary Analysis of the Single Ventricle Reconstruction Trial. 
  • Tacrolimus with mycophenolate mofetil (MMF) or sirolimus vs. cyclosporine with MMF in cardiac transplant patients: 1-year report. 
  • Technical performance score is associated with outcomes after the Norwood procedure. 
  • Ten-year experience with extended criteria cardiac transplantation. 
  • The Evolving Surgical Burden of Fontan Failure: An Analysis of The Society of Thoracic Surgeons Congenital Heart Surgery Database. 
  • The Future of heart procurement with donation after circulatory death: Current practice and opportunities for advancement. 
  • The HVAD Left Ventricular Assist Device: Risk Factors for Neurological Events and Risk Mitigation Strategies. 
  • The HeartMate 6. 
  • The International Society of Heart and Lung Transplantation Guidelines for the care of heart transplant recipients. 
  • The association with organ procurement techniques and early cardiac transplant outcomes using cardiac MRI. 
  • The change in B-type natriuretic peptide levels over time predicts significant rejection in cardiac transplant recipients. 
  • The combined effects of brain death and cardiac graft preservation on cardiopulmonary hemodynamics and function before and after subsequent heart transplantation. 
  • The economics of heart failure. 
  • The effect of 15-deoxyspergualin on hamster-to-rat cardiac xenograft survival. 
  • The effect of TLI and cyclosporine on xenograft survival. 
  • The effect of beta-adrenergic blockers on the prognostic value of peak exercise oxygen uptake in patients with heart failure. 
  • The effect of cyclosporine, total lymphoid irradiation, and cobra venom factor on hyperacute rejection. 
  • The effect of pretreatment with class I major histocompatibility complex (MHC) antigens on hepatic or cardiac allograft survival in the rat. 
  • The effect of soluble complement receptor type 1 on hyperacute allograft rejection. 
  • The effect of soluble complement receptor type 1 on hyperacute rejection of porcine xenografts. 
  • The effect of soluble complement receptor type 1 on hyperacute xenograft rejection. 
  • The future direction of the adult heart allocation system in the United States. 
  • The heart is just a muscle. 
  • The heart transplant allocation change attenuates but does not eliminate blood group O waitlist outcome disadvantage. 
  • The impact of donor-recipient sex matching on survival after orthotopic heart transplantation: analysis of 18 000 transplants in the modern era. 
  • The impact of race on survival after heart transplantation: an analysis of more than 20,000 patients. 
  • The incidence, risk factors, and outcomes associated with late right-sided heart failure in patients supported with an axial-flow left ventricular assist device. 
  • The influence of RS-61443 on antibody-mediated rejection. 
  • The influence of dose and dose rate of total lymphoid irradiation in the rat cardiac allograft model. 
  • The influence of institutional volume on the incidence of complications and their effect on mortality after heart transplantation. 
  • The natural history of renal function following orthotopic heart transplant. 
  • The new United States heart allocation policy: Progress through collaborative revision. 
  • The potential of xenotransplants. 
  • The role of anti-Galalpha1-3Gal antibodies in acute vascular rejection and accommodation of xenografts. 
  • The role of antibodies in acute vascular rejection of pig-to-baboon cardiac transplants. 
  • The role of natural anti-Gal alpha 1-3Gal antibodies in hyperacute rejection of pig-to-baboon cardiac xenotransplants. 
  • The spectrum of ciclosporin nephrotoxicity. 
  • The use of genome sequencing to investigate an outbreak of hospital-acquired mucormycosis in transplant patients. 
  • Thoracic organ transplantation at Papworth Hospital. 
  • Thoratec VAD system as a bridge to heart transplantation. 
  • Three-dimensional images of coronary arteries after heart transplantation using electron-beam computed tomography data with volume rendering. 
  • Thrombus on the inflow cannula of the HeartWare HVAD: an update. 
  • Timing and Number of Cutaneous Squamous Cell Carcinomas in Transplant Recipients. 
  • Timing of cardiac transplantation in patients with heart failure receiving beta-adrenergic blockers. 
  • Total lymphoid irradiation and cyclosporine prolongs cardiac allograft survival in the sensitized rat model. 
  • Total lymphoid irradiation for cardiac xenotransplantation in nonhuman primates. 
  • Transplant Center Variability in Organ Offer Acceptance and Mortality Among US Patients on the Heart Transplant Waitlist. 
  • Transplant-Free Survival and Interventions at 6 Years in the SVR Trial. 
  • Transplantation of high panel-reactive antibody left ventricular assist device patients without crossmatch using on-bypass pheresis and alemtuzumab. 
  • Transplanting a heart with a persistent left superior vena cava. 
  • Trends and Characteristics of Hospitalizations in Patients With Heart Transplant. 
  • Trends and Outcomes of Cardiac Transplantation in the Lowest Urgency Candidates. 
  • Trends and outcomes of cardiac transplantation from donors dying of drug intoxication. 
  • Trends and outcomes of patients with adult congenital heart disease and pulmonary hypertension listed for orthotopic heart transplantation in the United States. 
  • Trends in cardiac surgery-associated acute renal failure in the United States: a disproportionate increase after heart transplantation. 
  • Trends in cardiovascular medicine: Update on cardiac transplantation. 
  • Tricuspid Valve Regurgitation Immediately After Heart Transplant and Long-Term Outcomes. 
  • Two Cases of Late Shone Syndrome With Pulmonary Hypertension: Heart-Lung Transplant or Valve Surgery? 
  • Two-stage total cardioaortic replacement for end-stage heart and aortic disease in Marfan syndrome: case report and review of the literature. 
  • Unaltered graft survival and intragraft lymphocytes infiltration in the cardiac allograft of Cxcr3-/- mouse recipients. 
  • Unethical studies on transplantation in cardiothoracic surgery journals. 
  • Unexpected abrupt increase in left ventricular assist device thrombosis. 
  • Use of Temporary Mechanical Circulatory Support for Management of Cardiogenic Shock Before and After the United Network for Organ Sharing Donor Heart Allocation System Changes. 
  • Use of Two Intracorporeal Ventricular Assist Devices As a Total Artificial Heart. 
  • Use of a continuous-flow device in patients awaiting heart transplantation. 
  • Use of donor serum to prevent passive transfer of hyperacute rejection. 
  • Usefulness of left ventricular inflow Doppler in predicting rejection in pediatric cardiac transplant recipients. 
  • VA-ECMO for cardiogenic shock in the contemporary era of heart transplantation: Which patients should be urgently transplanted? 
  • Validation of donor fraction cell-free DNA with biopsy-proven cardiac allograft rejection in children and adults. 
  • Variable allograft responses to pretreatment with donor splenocytes treated with mitomycin C in the rat. 
  • Variables of importance in the Scientific Registry of Transplant Recipients database predictive of heart transplant waitlist mortality. 
  • Ventricular Assist Device Utilization in Heart Transplant Candidates: Nationwide Variability and Impact on Waitlist Outcomes. 
  • Warfarin therapy does not increase bleeding in patients undergoing heart transplantation. 
  • What If the Destination Is Transplant? Outcomes of Destination Therapy Patients Who Were Transplanted. 
  • When the heart runs out of heartbeats: treatment options for refractory end-stage heart failure. 
  • Worldwide Experience of a Durable Centrifugal Flow Pump in Pediatric Patients. 
  • Xenograft survival in two species combinations using total-lymphoid irradiation and cyclosporine. 
• 

  Keywords of People

  • Carboni, Michael Paul, Associate Professor of Pediatrics, Pediatrics, Cardiology
  • Gunn, Michael Dee, Professor of Medicine, Integrative Immunobiology
  • Holley, Christopher Lee, Associate Professor of Medicine, Molecular Genetics and Microbiology
  • Mentz, Robert John, Associate Professor of Medicine, Medicine, Cardiology
  • Milano, Carmelo Alessio, Joseph W. and Dorothy W. Beard Distinguished Professor of Experimental Surgery, Surgery, Cardiovascular and Thoracic Surgery
  • O'Connor, Christopher Michael, Adjunct Professor in the Department of Medicine, Medicine, Clinical Pharmacology
  • Patel, Uptal Dinesh, Adjunct Professor in the Department of Medicine, Medicine, Nephrology
  • Patz Jr., Edward F., James and Alice Chen Distinguished Professor of Radiology, Pathology
  • Rao, Vishal, House Staff, Medicine, Cardiology
  • Russell, Stuart Dean, Professor of Medicine, Medicine, Cardiology
  • Swaminathan, Madhav, Professor of Anesthesiology, Anesthesiology, Cardiothoracic